Lymphoma (follicular, rituximab-refractory) – obinutuzumab (with bendamustine) [ID841]
The National Institute for Health and Care Excellence has opened a consultation on the use of obinutuzumab for the treatment … read more »
The National Institute for Health and Care Excellence has opened a consultation on the use of obinutuzumab for the treatment … read more »